ArticleSurgical neurology international2026
Nasal morbidity and complications after endoscopic transsphenoidal pituitary adenoma surgery.
Article in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endoscopic transnasal transsphenoidal (ETT) surgery has become the standard approach for pituitary adenoma resection, yet postoperative nasal morbidity remains a concern. This study aims to evaluate rhinologic outcomes after ETT surgery, characterize the types and frequencies of postoperative nasal complications, and assess the effectiveness of treatment strategies. The primary research question addresses the incidence and reversibility of nasal morbidity following ETT surgery. Methods: A retrospective review was performed on 414 patients who underwent ETT surgery for pituitary adenomas at our institution between August 2015 and August 2025. Postoperative nasal complaints and complications were documented, including epistaxis, sinusitis, nasal adhesions, olfactory disturbances, and crusting. Clinical outcomes following targeted treatments were analyzed. Results: Seventeen patients (4.1%) experienced postoperative nasal complications. These included epistaxis ( Conclusion: Postoperative rhinologic complication rates following ETT surgery for pituitary adenomas are low and generally reversible with appropriate management. These findings support the safety of the ETT approach while emphasizing the importance of careful perioperative planning and postoperative nasal care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.